Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention

Anna Aiello, Farzin Farzaneh, Giuseppina Candore, Calogero Caruso, Sergio Davinelli, Caterina Maria Gambino, Mattia Emanuela Ligotti, Nahid Zareian, Giulia Accardi, Anna Aiello, Farzin Farzaneh, Giuseppina Candore, Calogero Caruso, Sergio Davinelli, Caterina Maria Gambino, Mattia Emanuela Ligotti, Nahid Zareian, Giulia Accardi

Abstract

Aging is accompanied by remodeling of the immune system. With time, this leads to a decline in immune efficacy, resulting in increased vulnerability to infectious diseases, diminished responses to vaccination, and a susceptibility to age-related inflammatory diseases. An age-associated immune alteration, extensively reported in previous studies, is the reduction in the number of peripheral blood naïve cells, with a relative increase in the frequency of memory cells. These two alterations, together with inflamm-aging, are considered the hallmarks of immunosenescence. Because aging is a plastic process, it is influenced by both nutritional and pharmacological interventions. Therefore, the role of nutrition and of immunomodulation in immunosenescence is discussed, due to the multifactorial influence on these hallmarks. The close connection between nutrition, intake of bioactive nutrients and supplements, immune function, and inflammation demonstrate the key role of dietary strategies as regulators of immune response and inflammatory status, hence as possible modulators of the rate of immunosenescence. In addition, potential options for therapeutic intervention are clarified. In particular, the use of interleukin-7 as growth factor for naïve T cells, the function of checkpoint inhibitors in improving T cell responses during aging and, the potential of drugs that inhibit mitogen-activated protein kinases and their interaction with nutrient signaling pathways are discussed. Finally, it is suggested that the inclusion of appropriate combinations of toll-like receptor agonists may enhance the efficacy of vaccination in older adults.

Keywords: aging; immunomodulation; immunosenescence; immunotherapy; nutrition.

Copyright © 2019 Aiello, Farzaneh, Candore, Caruso, Davinelli, Gambino, Ligotti, Zareian and Accardi.

Figures

Figure 1
Figure 1
Schematic changes occur during aging. The immunosenescence in older people is characterized by thymic involution, altered T and B cell responses, altered naïve/memory ratio, increased serum levels of IgG and IgA, a chronic low grade inflammation, and a poor response to newly encountered microbial antigens, including vaccines. The reduced ability to respond to new antigens, the accumulation of memory T cells and the lingering level of low-grade inflammation “inflamm-aging”) are considered hallmarks of immunosenescence. See the text for the acronyms. increase; decrease.
Figure 2
Figure 2
Overview of the main strategies of immunomodulation. (A) In age-related diseases, in particular in some metastatic cancers, the use of the monoclonal antibody (such as Nivolumab, a PD-1 inhibitor) alone or in combination with other antagonists (PD-L1 antibody, like Atezolizumab) shows positive results on T cell activities in older adults. These cells became able to respond to the action of their inhibitory receptors with a recovery of cytotoxic activity. (B) In old models, with Lack of activity of CD8+, it is possible to rejuvenate CD8+ T cell responses in an autophagy dependent manner, using the polyamine compound spermidine. Spermidine induces autophagy and prolongs lifespan in model organisms. Moreover, in the CD8+/CD45RA+/CCR7− T cells, a block at the level of MAPK p38 by sestrins causes age-related signaling defects. The knockout of sMAC restores T cell activity (antigen-specific proliferation and cytokine production) in older humans, and enhances responsiveness to influenza vaccination in old mice. (C) GATOR and RAG A/B GTPase make a sestrin-inhibitory complex that involves the mTOR pathway. In particular, sestrins stimulate the activation of AMPK (by an unknown mechanism), inhibiting mTORC1 signaling. In addition, mTOR inhibitors, i.e., rapamycin and everolimus, are promising treatments for several age-related pathologies, including immunosenescence, prolonging lifespan. A soft inhibition of mTOR could be beneficial for immune function in older adults, although mTOR activity inhibits autophagy, and involves a decrease in the percentage of PD-1 positive T cells. See the text for the acronyms.

References

    1. Available, online at:
    1. Avery P, Barzilai N, Benetos A, Bilianou H, Capri M, Caruso C, et al. . Ageing, longevity, exceptional longevity and related genetic and non genetics markers: panel statement. Curr Vasc Pharmacol. (2014) 12:659–61. 10.2174/1570161111666131219101226
    1. Caruso C, Vasto S. Immunity and aging. In: Ratcliffe MJH, editor. Encyclopedia of Immunobiology, Vol. 5 Oxford: Academic Press; (2016). p. 127–32.
    1. Walford RL. The Immunologic Theory of Aging. Copenhagen: Munksgaard: (1969).
    1. Nikolich-Žugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. (2018) 19:10–9. 10.1038/s41590-017-0006-x
    1. Pawelec G. Hallmarks of human “immunosenescence”: adaptation or dysregulation? Immun Ageing. (2012) 9:15 10.1186/1742-4933-9-15
    1. Aiello A, Accardi G, Candore G, Caruso C, Colomba C, Di Bona D, et al. . Role of immunogenetics in the outcome of HCMV infection: implications for ageing. Int J Mol Sci. (2019) 20:E685. 10.3390/ijms20030685
    1. Caruso C, Accardi G, Virruso C, Candore G. Sex, gender and immunosenescence: a key to understand the different lifespan between men and women? Immun Ageing. (2013) 10:20. 10.1186/1742-4933-10-20
    1. Accardi G, Caruso C. Immune-inflammatory responses in the elderly: an update. Immun Ageing. (2018)15:11. 10.1186/s12979-018-0117-8
    1. Turner JE. Is immunosenescence influenced by our lifetime “dose” of exercise? Biogerontology. (2016) 17:581–602. 10.1007/s10522-016-9642-z. Erratum in: Biogerontology. (2016) 7:783.
    1. Maijó M, Clements SJ, Ivory K, Nicoletti C, Carding SR. Nutrition, diet and immunosenescence. Mech Ageing Dev. (2014) 136–137:116–28. 10.1016/j.mad.2013.12.003
    1. Ostan R, Monti D, Gueresi P, Bussolotto M, Franceschi C, Baggio G. Gender, aging and longevity in humans: an update of an intriguing/neglected scenario paving the way to a gender-specific medicine. Clin Sci. (2016) 130:1711–25. 10.1042/CS20160004
    1. Hirokawa K, Utsuyama M, Hayashi Y, Kitagawa M, Makinodan T, Fulop T. Slower immune system aging in women versus men in the Japanese population. Immun Ageing. (2013) 10:19. 10.1186/1742-4933-10-19
    1. Dudkowska M, Janiszewska D, Karpa A, Broczek K, Dabrowski M, Sikora E. The role of gender and labour status in immunosenescence of 65+ Polish population. Biogerontology. (2017) 18:581–90. 10.1007/s10522-017-9702-z
    1. Fülöp T, Larbi A, Pawelec G. Human T cell aging and the impact of persistent viral infections. Front Immunol. (2013) 4:271. 10.3389/fimmu.2013.00271
    1. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev. (2005) 205:257–68. 10.1111/j.0105-2896.2005.00271.x
    1. Jergović M, Contreras NA, Nikolich-Žugich J. Impact of CMV upon immune aging: facts and fiction. Med Microbiol Immunol. (2019) 208:263–9. 10.1007/s00430-019-00605-w
    1. Nikolich-Žugich J, van Lier RAW. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th international workshop on CMV and immunosenescence. Geroscience. (2017) 39:245–9. 10.1007/s11357-017-9984-8
    1. Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, et al. . Interventions to Slow aging in humans: are we ready? Aging Cell. (2015) 14:497–510. 10.1111/acel.12338
    1. Aiello A, Caruso C, Accardi G. Slow-aging diets. In: Gu D, Dupre ME. editors. Encyclopedia of Gerontology and Population Aging. Springer Nature Switzerland AG; (2019). 10.1007/978-3-319-69892-2_134-1
    1. Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal. (2011) 14:1551–85. 10.1089/ars.2010.3228
    1. Pawelec G. Age and immunity: What is “immunosenescence”? Exp Gerontol. (2018) 105:4–9. 10.1016/j.exger.2017.10.024
    1. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. (2013)14:428–36. 10.1038/ni.2588
    1. Pinti M, Appay V, Campisi J, Frasca D, Fülöp T, Sauce D, et al. . Aging of the immune system: focus on inflammation and vaccination. Eur J Immunol. (2016) 46:2286–301. 10.1002/eji.201546178
    1. Metcalf TU, Cubas RA, Ghneim K, Cartwright MJ, Grevenynghe JV, Richner JM, et al. . Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors. Aging Cell. (2015) 14:421–32. 10.1111/acel.12320
    1. Müller L, Fülöp T, Pawelec G. Immunosenescence in vertebrates and invertebrates. Immun Ageing. (2013) 10:12. 10.1186/1742-4933-10-12
    1. Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. (2018) 154:3–20. 10.1111/imm.12888
    1. Adams S. Toll-like receptor agonists in cancer therapy. Immunotherapy. (2009) 1:949–64. 10.2217/imt.09.70
    1. Gambino CM, Vasto S, Ioannou K, Candore G, Caruso C, Farzaneh F. Triggering of Toll-like receptors in the elderly. A pilot stdudy relevant for vaccination. In: Accardi G, Caruso C. editors. Updates in Pathobiology: Causality and Chance in Ageing, Age-Related Diseases and Longevity. Palermo: Palermo University Press; (2017). p. 13–23.
    1. Miyaji EN, Carvalho E, Oliveira ML, Raw I, Ho PL. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. Braz J Med Biol Res. (2011) 44:500–13. 10.1590/s0100-879x2011007500064
    1. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. . Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. (2015) 372:2087–96. 10.1056/NEJMoa1501184
    1. Sharma S, Dominguez AL, Hoelzinger DB, Lustgarten J. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged. Cancer Immunol Immunother. (2008) 57:549–61. 10.1007/s00262-007-0393-1
    1. Schulz AR, Mälzer JN, Domingo C, Jürchott K, Grützkau A, Babel N, et al. . Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans. J Immunol. (2015) 195:4699–711. 10.4049/jimmunol.1500598
    1. Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, et al. . Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. (2005) 16:513–33. 10.1016/j.cytogfr.2005.05.004
    1. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, et al. . Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science. (1993) 262:1877–80.
    1. Shanley DP, Aw D, Manley NR, Palmer DB. An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. (2009) 30:374–81. 10.1016/j.it.2009.05.001
    1. Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine. (2000) 18:1717–20. 10.1016/S0264-410X(99)00513-7
    1. Lanna A, Henson SM, Escors D, Akbar AN. The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol. (2014) 15:965–72. 10.1038/ni.2981
    1. Chou JP, Effros RB. T cell replicative senescence in human aging. Curr Pharm Des. (2013) 19:1680–98. 10.2174/1381612811319090016
    1. Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, et al. . Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol. (2014) 192:2143–55. 10.4049/jimmunol.1301721
    1. Effros RB, Boucher N, Porter V, Zhu X, Spaulding C, Walford RL, Kronenberg M, Cohen D, Schächter F. Decline in CD28+ T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. (1994) 29:601–9.
    1. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodon G. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28− cytotoxic effector clones. Int Immunol. (1999) 11:229–41.
    1. Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood. (2002) 100:3698–702. 10.1182/blood-2002-02-0657
    1. Plunkett FJ, Franzese O, Finney HM, Fletcher JM, Belaramani LL, Salmon M, et al. . The loss of telomerase activity in highly differentiated CD8+CD28−CD27− T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol. (2007) 178:7710–9. 10.4049/jimmunol.178.12.7710
    1. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr Opin Immunol. (2009) 21:440–5. 10.1016/j.coi.2009.05.012
    1. Nikolich-Zugich J, Goodrum F, Knox K, Smithey MJ. Known unknowns: how might the persistent herpesvirome shape immunity and aging? Curr Opin Immunol. (2017) 48:23–30. 10.1016/j.coi.2017.07.011
    1. Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol. (2014) 54:1–5. 10.1016/j.exger.2013.11.010
    1. Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell. 2012 11:912–5. 10.1111/j.1474-9726.2012.00849.x
    1. Gilden D, Nagel MA, Cohrs RJ. Varicella-zoster. Handb Clin Neurol. (2014) 123:265–83. 10.1016/B978-0-444-53488-0.00012-2
    1. Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, et al. . Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. (1999) 90:213–9. 10.1006/clim.1998.4638
    1. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, et al. . Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. (2002) 169:1984–92. 10.4049/jimmunol.169.4.1984
    1. Riddell NE, Griffiths SJ, Rivino L, King DCB, Teo GH, Henson SM, et al. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults. Immunology. (2015) 144:549–60. 10.1111/imm.12409
    1. Parry HM, Zuo J, Frumento G, Mirajkar N, Inman C, Edwards E, et al. . Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing. (2016) 13:1. 10.1186/s12979-015-0056-6
    1. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine. (2015) 33:1433–9. 10.1016/j.vaccine.2015.01.071
    1. Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJ, Onengut-Gumuscu S, et al. . Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med. (2015) 7:281ra43. 10.1126/scitranslmed.aaa2293
    1. Weltevrede M, Eilers R, de Melker HE, van Baarle D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol. (2016) 77:87–95. 10.1016/j.exger.2016.02.005
    1. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. (2014) 69:S4–9. 10.1093/gerona/glu057
    1. Leonardi GC, Accardi G, Monastero R, Nicoletti F, Libra M. Ageing: from inflammation to cancer. Immun Ageing. (2018) 15:1. 10.1186/s12979-017-0112-5
    1. Puzianowska-Kuznicka M, Owczarz M, Wieczorowska-Tobis K, Nadrowski P, Chudek J, Slusarczyk P, et al. . Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing. (2016) 13:21. 10.1186/s12979-016-0076-x
    1. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, et al. . Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing. (2005) 2:8. 10.1186/1742-4933-2-8
    1. De la Fuente M, Miquel J. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des. (2009) 15:3003–26. 10.2174/138161209789058110
    1. Biswas SK. Does the Interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev. (2016) 2016:5698931. 10.1155/2016/5698931
    1. Pinti M, Cevenini E, Nasi M, De Biasi S, Salvioli S, Monti D, et al. . Circulating mitochondrial DNA increases with age and is a familiar trait: implications for “inflamm-aging”. Eur J Immunol. (2014) 44:1552–62. 10.1002/eji.201343921
    1. Accardi G, Shivappa N, Di Maso M, Hébert JR, Fratino L, Montella M, et al. Dietary inflammatory index and cancer risk in the elderly: a pooled-analysis of Italian case-control studies. Nutrition. (2019) 63–64:205–10. 10.1016/j.nut.2019.02.008
    1. Aiello A, Accardi G, Candore G, Gambino CM, Mirisola M, Taormina G, et al. . Nutrient sensing pathways as therapeutic targets for healthy ageing. Expert Opin Ther Targets. (2017) 21:371–80. 10.1080/14728222.2017.1294684
    1. Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, et al. . Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des. (2010) 16:609–18. 10.2174/138161210790883840
    1. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during ageing: NF-kB signaling is the molecular culprit of inflamm-ageing. Ageing Res Rev. (2008) 7:83–105. 10.1016/j.arr.2007.09.002
    1. Vasto S, Buscemi S, Barera A, Di Carlo M, Accardi G, Caruso C. Mediterranean diet and healthy ageing: a Sicilian perspective. Gerontology. (2014) 60:508–18. 10.1159/000363060
    1. Frasca D, Diaz A, Romero M, Ferracci F, Blomberg BB. MicroRNAs miR-155 and miR-16 decrease AID and E47 in B cells from elderly individuals. J Immunol. (2015) 195:2134–40. 10.4049/jimmunol.1500520
    1. Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, Rouphael N, et al. . Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures. Immunity. (2015) 43:1186–98. 10.1016/j.immuni.2015.11.012
    1. Bulati M, Buffa S, Candore G, Caruso C, Dunn-Walters DK, Pellicanò M, et al. . B cells and immunosenescence: a focus on IgG+IgD−CD27− (DN) B cells in aged humans. Ageing Res Rev. (2011) 10:274–84. 10.1016/j.arr.2010.12.002
    1. Frasca D, Van der Put E, Riley RL, Blomberg BB. Reduced Ig class switch in aged mice correlates with decreased E47 and activation-induced cytidine deaminase. J Immunol. (2004) 172:2155–62. 10.4049/jimmunol.172.4.2155
    1. Frasca D, Diaz A, Romero M, Blomberg BB. The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations. Vaccine. (2016) 34:2834–40. 10.1016/j.vaccine.2016.04.023
    1. Colonna-Romano G, Bulati M, Aquino A, Scialabba G, Candore G, Lio D, et al. . B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev. (2003) 124:389–93. 10.1016/s0047-6374(03)00013-7
    1. Bulati M, Caruso C, Colonna-Romano G. From lymphopoiesis to plasma cells differentiation, the age-related modifications of B cell compartment are influenced by “inflamm-ageing”. Ageing Res Rev. (2017) 36:125–36. 10.1016/j.arr.2017.04.001
    1. Listì F, Candore G, Modica MA, Russo M, Di Lorenzo G, Esposito-Pellitteri M, et al. . A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci. (2006) 1089:487–95. 10.1196/annals.1386.013
    1. Colonna-Romano G, Bulati M, Aquino A, Pellicanò M, Vitello S, Lio D, et al. . A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev. (2009) 130:681–90. 10.1016/j.mad.2009.08.003
    1. Maggini S, Pierre A, Calder PC. Immune function and micronutrient requirements change over the life course. Nutrients. (2018) 10:E1531. 10.3390/nu10101531
    1. Lesourd B. Nutritional factors and immunological ageing. Proc Nutr Soc. (2006) 65:319–25. 10.1079/PNS2006507
    1. Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J, et al. . An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. (2016) 2016:8426874. 10.1155/2016/8426874
    1. Choi IY, Lee C, Longo VD. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence. Mol Cell Endocrinol. (2017) 455:4–12. 10.1016/j.mce.2017.01.042
    1. Ongrádi J, Kövesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing. (2010) 7:7. 10.1186/1742-4933-7-7
    1. Trichopoulou A, Benetou V. Impact of Mediterranean diet on longevity. In: Caruso C. editor. Centenarians. An Example of Positive Biology. Culemborg: Springer; (2019). p. 161–8.
    1. Martinez-Gonzalez MA, Bes-Rastrollo M, Serra-Majem L, Lairon D, Estruch R, Trichopoulou A. Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nutr Rev. (2009) 67:S111–6. 10.1111/j.1753-4887.2009.00172.x
    1. Mitsou EK, Kakali A, Antonopoulou S, Mountzouris KC, Yannakoulia M, Panagiotakos DB, et al. . Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population. Br J Nutr. (2017) 117:1645–55. 10.1017/S0007114517001593
    1. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr. (2010) 92:1189–96. 10.3945/ajcn.2010.2967
    1. Gambino CM, Accardi G, Aiello A, Candore G, Dara-Guccione G, Mirisola M, et al. . Effect of extra virgin olive oil and table olives on the immuneinflammatory responses: potential clinical applications. Endocr Metab Immune Disord Drug Targets. (2018) 18:14–22. 10.2174/1871530317666171114113822
    1. Accardi G, Aiello A, Gambino CM, Virruso C, Caruso C, Candore G. Mediterranean nutraceutical foods: Strategy to improve vascular ageing. Mech Ageing Dev. (2016) 159:63–70. 10.1016/j.mad.2016.02.007
    1. Accardi G, Aiello A, Gargano V, Gambino CM, Caracappa S, Marineo S, et al. . Nutraceutical effects of table green olives: a pilot study with Nocellara del Belice olives. Immun Ageing. (2016) 13:11. 10.1186/s12979-016-0067-y
    1. Casas R, Sacanella E, Urpí-Sardà M, Corella D, Castañer O, Lamuela-Raventos RM, et al. . Long-term immunomodulatory effects of a mediterranean diet in adults at high risk of cardiovascular disease in the PREvención con DIeta MEDiterránea (PREDIMED) randomized controlled trial. J Nutr. (2016) 146:1684–93. 10.3945/jn.115.229476
    1. Chung KW, Kim DH, Park MH, Choi YJ, Kim ND, Lee J, et al. . Recent advances in calorie restriction research on aging. Exp Gerontol. (2013) 48:1049–53. 10.1016/j.exger.2012.11.007
    1. Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of aging: molecular modulation by calorie restriction. Ann N Y Acad Sci. (2001) 928:327–35. 10.1111/j.1749-6632.2001.tb05662.x
    1. Neuvonen PT, Salo M. Effects of short-term starvation on the immune response. Nutr Res. (1984) 4:771–6.
    1. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. (2016) 23:1060–65. 10.1016/j.cmet.2016.05.011
    1. Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, et al. . Metformin improves healthspan and lifespan in mice. Nat Commun. (2013) 4:2192. 10.1038/ncomms312
    1. Saisho Y. Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets. (2015) 15:196–205. 10.2174/1871530315666150316124019
    1. Son HJ, Lee J, Lee SY, Kim EK, Park MJ, Kim KW, et al. . Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis. Mediat Inflamm. (2014) 2014:973986. 10.1155/2014/973986
    1. Nova E, Warnberg J, Gomez-Martinez S, Diaz LE, Romeo J, Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr. (2007) 98:S90–5. 10.1017/S0007114507832983
    1. Shlisky J, Bloom DE, Beaudreault AR, Tucker KL, Keller HH, Freund-Levi Y, et al. . Nutritional considerations for healthy aging and reduction in age-related chronic disease. Adv Nutr. (2017) 8:17–26. 10.3945/an.116.013474
    1. Leslie W, Hankey C. Aging, nutritional status and health. Healthcare (Basel). (2015) 3:648–58. 10.3390/healthcare3030648
    1. Wu D, Lewis ED, Pae M, Meydani SN. Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front Immunol. (2019) 9:3160. 10.3389/fimmu.2018.03160
    1. Pae M, Meydani SN, Wu D. The role of nutrition in enhancing immunity in aging. Aging Dis. (2012) 3:91–129.
    1. Elmadfa I, Meyer A, Nowak V, Hasenegger V, Putz P, Verstraeten R, et al. . European Nutrition and Health Report 2009. Ann Nutr Metab. (2009) 55:1–40. 10.1159/000244607
    1. Haase H, Rink L. The immune system and the impact of zinc during aging. Immun Ageing. (2009) 6:9. 10.1186/1742-4933-6-9
    1. Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. (2008) 43:370–7. 10.1016/j.exger.2007.10.013
    1. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. (2008) 14:353–7. 10.2119/2008-00033
    1. Maywald M, Wessels I, Rink L. Zinc signals and immunity. Int J Mol Sci. (2017) 18:E2222. 10.3390/ijms18102222
    1. Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. (2004) 24:277–98. 10.1146/annurev.nutr.24.012003.132454
    1. Consolini R, Legitimo A, Calleri A, Milani M. Distribution of age-related thymulin titres in normal subjects through the course of life. Clin Exp Immunol. (2000) 121:444–7. 10.1046/j.1365-2249.2000.01315.x
    1. Savino W, Dardenne M. Neuroendocrine control of thymus physiology. Endocr Rev. (2000) 21:412–43. 10.1210/edrv.21.4.0402
    1. Fortes C, Forastiere F, Agabiti N, Fano V, Pacifici R, Virgili F, et al. . The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc. (1998) 46:19–26.
    1. Lee SR. Critical role of zinc as either an antioxidant or a prooxidant in cellular systems. Oxid Med Cell Longev. (2018) 2018:9156285 10.1155/2018/9156285
    1. Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, et al. . Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. (1997) 277:1380–6.
    1. De la Fuente M, Hernanz A, Guayerbas N, Victor VM, Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic Res. (2008) 42:272–80. 10.1080/10715760801898838
    1. Pallast EG, Schouten EG, de Waart FG, Fonk HC, Doekes G, von Blomberg BM, et al. . Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr. (1999) 69:1273–81.
    1. Huijskens MJ, Walczak M, Sarkar S, Atrafi F, Senden-Gijsbers BL, Tilanus MG, et al. . Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy. Cytotherapy. (2015) 17:613–20. 10.1016/j.jcyt.2015.01.004
    1. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press (US) (2000).
    1. Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. (2017) 9:E1021. 10.3390/nu9091021
    1. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. (2001) 74:833–9. 10.1093/ajcn/74.6.833
    1. Dong H, Rowland I, Thomas LV, Yaqoob P. Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr. (2013) 52:1853–63. 10.1007/s00394-012-0487-1
    1. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. (2008) 88:1438–46. 10.3945/ajcn.2008.26242
    1. Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, et al. . Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. (2015) 12:24. 10.1186/s12979-015-0051-y
    1. Landete JM, Gaya P, Rodríguez E, Langa S, Peirotén Á, Medina M, et al. . Probiotic bacteria for healthier aging: immunomodulation and metabolism of phytoestrogens. Biomed Res Int. (2017) 2017:5939818. 10.1155/2017/5939818
    1. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. (2019) 25:716–29. 10.1038/s41591-019-0439-x
    1. Bunout D, Hirsch S, Pía de la Maza M, Muñoz C, Haschke F, Steenhout P, et al. . Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J Parenter Enteral Nutr. (2002) 26:372–6. 10.1177/0148607102026006372
    1. Aiello A, Accardi G, Candore G, Carruba G, Davinelli S, Passarino G, et al. . Nutrigerontology: a key for achieving successful ageing and longevity. Immun Ageing. (2016) 13:17. 10.1186/s12979-016-0071-2
    1. Ferrari CK. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology. (2004) 5:275–89. 10.1007/s10522-004-2566-z
    1. Davinelli S, Maes M, Corbi G, Zarrelli A, Willcox DC, Scapagnini G. Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges. Immun Ageing. (2016) 13:16. 10.1186/s12979-016-0070-3
    1. Gupta C, Prakash D. Nutraceuticals for geriatrics. J Tradit Complement Med. (2014) 5:5–14. 10.1016/j.jtcme.2014.10.004
    1. Gurău F, Baldoni S, Prattichizzo F, Espinosa E, Amenta F, Procopio AD, et al. . Anti-senescence compounds: a potential nutraceutical approach to healthy aging. Ageing Res Rev. (2018) 46:14–31. 10.1016/j.arr.2018.05.001
    1. López-Varela S, González-Gross M, Marcos A. Functional foods and the immune system: a review. Eur J Clin Nutr. (2002) 56:S29–33. 10.1038/sj.ejcn.1601481
    1. Molfino A, Gioia G, Rossi Fanelli F, Muscaritoli M. The role for dietary omega-3 fatty acids supplementation in older adults. Nutrients. (2014) 6:4058–73. 10.3390/nu6104058
    1. Pae M, Wu D. Nutritional modulation of age-related changes in the immune system and risk of infection. Nutr Res. (2017) 41:14–35. 10.1016/j.nutres.2017.02.001
    1. Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients. (2018) 10:E522. 10.3390/nu10040522
    1. Wood SM, Beckham C, Yosioka A, Darban H, Watson RR. Beta-carotene and selenium supplementation enhances immune response in aged humans. Integr Med. (2000) 2:85–92.
    1. Jyonouchi H, Zhang L, Gross M, Tomita Y. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr Cancer. (1994) 21:47–58. 10.1080/01635589409514303
    1. Farges MC, Minet-Quinard R, Walrand S, Thivat E, Ribalta J, Winklhofer-Roob B, et al. . Immune status is more affected by age than by carotenoid depletion-repletion in healthy human subjects. Br J Nutr. (2012) 108:2054–65. 10.1017/S0007114512000177
    1. Watson RR, Prabhala RH, Plezia PM, Alberts DS. Effect of beta-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship. Am J Clin Nutr. (1991) 53:90–4.
    1. Prabhala RH, Garewal HS, Hicks MJ, Sampliner RE, Watson RR. The effects of 13-cis-retinoic acid and beta-carotene on cellular immunity in humans. Cancer. (1991) 67:1556–60.
    1. Santos MS, Meydani SN, Leka L, Wu D, Fotouhi N, Meydani M, et al. . Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation. Am J Clin Nutr. (1996) 64:772–7. 10.1093/ajcn/64.5.772
    1. Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. (2010) 2:1231–46. 10.3390/nu2121231
    1. Davinelli S, Scapagnini G. Polyphenols: a promising nutritional approach to prevent or reduce the progression of prehypertension. High Blood Press Cardiovasc Prev. (2016) 23:197–202. 10.1007/s40292-016-0149-0
    1. Monagas M, Khan N, Andres-Lacueva C, Casas R, Urpí-Sardà M, Llorach R, et al. . Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr. (2009) 90:1144–50. 10.3945/ajcn.2009.27716
    1. Miles EA, Zoubouli P, Calder PC. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition. (2005) 21:389–94. 10.1016/j.nut.2004.06.031
    1. Magrone T, Jirillo E. Disorders of innate immunity in human ageing and effects of nutraceutical administration. Endocr Metab Immune Disord Drug Targets. (2014) 14:272–82. 10.2174/1871530314666141010105540
    1. Magrone T, Jirillo E. Nutraceuticals in immunosenescence. In: Neves D. editor. Anti-Ageing Nutrients: Evidence-Based Prevention of Age-Associated Diseases. Oxford: Wiley Blackwell; (2015). p. 183–202.
    1. Yuan J, Lu L, Zhang Z, Zhang S. Dietary intake of resveratrol enhances the adaptive immunity of aged rats. Rejuv Res. (2012) 15:507–15. 10.1089/rej.2012.1321
    1. Calder PC. The 2008 ESPEN Sir David Cuthbertson Lecture: fatty acids and inflammation–from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr. (2010) 29:5–12. 10.1016/j.clnu.2009.11.003
    1. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, et al. . Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids. (2001) 36:1183–93. 10.1007/s11745-001-0831-4
    1. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr. (2001) 73:539–48. 10.1093/ajcn/73.3.539
    1. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr. (2001) 131:1918–27. 10.1093/jn/131.7.1918
    1. Rees D, Miles EA, Banerjee T, Wells SJ, Roynette CE, Wahle KW, et al. . Dose-related effects of eicosapentaenoic acid oninnate immune function in healthy humans: a comparison ofyoung and older men. Am J Clin Nutr. (2006) 83:331–42. 10.1093/ajcn/83.2.331
    1. Bechoua S, Dubois M, Véricel E, Chapuy P, Lagarde M, Prigent AF. Influence of very low dietary intake of marine oil on some functional aspects of immune cells in healthy elderly people. Br J Nutr. (2003) 89:523–31. 10.1079/BJN2002805
    1. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, et al. . Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr. (1991) 121:547–55. 10.1093/jn/121.4.547
    1. Masters AR, Haynes L, Su DM, Palmer DB. Immune senescence: significance of the stromal microenvironment. Clin Exp Immunol. (2017) 187:6–15. 10.1111/cei.12851
    1. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol. (2005) 174:6571–6. 10.4049/jimmunol.174.11.6571
    1. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, et al. . Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. (1994) 180:1955–60.
    1. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet. (1998) 20:394–7. 10.1038/3877
    1. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood. (2000) 96:2803–7.
    1. Gao J, Zhao L, Wan YY, Zhu B. Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy. Int J Mol Sci. (2015) 16:10267–80. 10.3390/ijms160510267
    1. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, et al. . Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med. (2000) 192:671–80. 10.1084/jem.192.5.671
    1. Rosenberg SA, Sportès C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, et al. . IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother. (2006) 29:313–9. 10.1097/01.cji.0000210386.55951.c2
    1. Lévy Y, Sereti I, Tambussi G, Routy JP, Lelièvre JD, Delfraissy JF, et al. . Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin Infect Dis. (2012) 55:291–300. 10.1093/cid/cis383
    1. Gui J, Zhu X, Dohkan J, Cheng L, Barnes PF, Su DM. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int Immunol. (2007) 19:1201–11. 10.1093/intimm/dxm095
    1. Elias R, Hartshorn K, Rahma O, Lin N, Snyder-Cappione JE. Aging, immune senescence, and immunotherapy: a comprehensive review. Semin Oncol. (2018) 45:187–200. 10.1053/j.seminoncol.2018.08.006
    1. McDermott DF, Atkins MB. PD-1 as a potential target in cancer therapy. Cancer Med. (2013) 2:662–73. 10.1002/cam4.106
    1. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. (2013) 13:227–42. 10.1038/nri3405
    1. Viganò S, Perreau M, Pantaleo G, Harari A. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol. (2012) 2012:485781. 10.1155/2012/485781
    1. Elias R, Morales J, Rehman Y, Khurshid H. Immune checkpoint inhibitors in older adults. Curr Oncol Rep. (2016) 18:47. 10.1007/s11912-016-0534-9
    1. Elias R, Karantanos T, Sira E, Hartshorn KL. Immunotherapy comes of age: immune aging & checkpoint inhibitors. J Geriatr Oncol. (2017) 8:229–35. 10.1016/j.jgo.2017.02.001
    1. Hurez V, Padrón ÁS, Svatek RS, Curiel TJ. Considerations for successful cancer immunotherapy in aged hosts. Clin Exp Immunol. (2017) 187:53–63. 10.1111/cei.12875
    1. Ghanizada M, Jakobsen KK, Grønhøj C, von Buchwald C. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: a systematic review. Oral Oncol. (2019) 90:67–73. 10.1016/j.oraloncology.2019.01.018
    1. Grossi F, Crinò L, Logroscino A, Canova S, Delmonte A, Melotti B, et al. . Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme. Eur J Cancer. (2018) 100:126–34. 10.1016/j.ejca.2018.05.015
    1. Knaus HA, Kanakry CG, Luznik L, Gojo I. Immunomodulatory drugs: immune checkpoint agents in acute leukemia. Curr Drug Targets. (2017) 18:315–331. 10.2174/1389450116666150518095346
    1. Nishijima TF, Muss HB, Shachar SS, Moschos SJ. Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis. Cancer Treat Rev. (2016) 45:30–7. 10.1016/j.ctrv.2016.02.006
    1. Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. (2017) 541:321–30. 10.1038/nature21349
    1. Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. (2018) 15:671–82. 10.1038/s41575-018-0025-6
    1. Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, et al. . Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. (2018) 359:91–7. 10.1126/science.aan3706
    1. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. . Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. (2018) 359:97–103. 10.1126/science.aan4236
    1. Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, et al. . Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. (2015) 350:1079–84. 10.1126/science.aad1329
    1. Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, et al. . Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. (2017) 28:1368–79. 10.1093/annonc/mdx108
    1. Kulpa DA, Lawani M, Cooper A, Peretz Y, Ahlers J, Sékaly RP. PD-1 coinhibitory signals: the link between pathogenesis and protection. Semin Immunol. (2013) 25: 219–27. 10.1016/j.smim.2013.02.002
    1. Patterson H, Nibbs R, McInnes I, Siebert S. Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol. (2014) 176:1–10. 10.1111/cei.12248
    1. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. (2002) 298:1911–2. 10.1126/science.1072682
    1. Henson SM, Lanna A, Riddell NE, Franzese O, Macaulay R, Griffiths SJ, et al. . p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells. J Clin Invest. (2014) 124:4004–16. 10.1172/JCI75051
    1. Jackson AM, Mulcahy LA, Porte J, Franks HA, El Refaee M, Wang Q, et al. . Role of mitogen-activated protein kinase and PI3K pathways in the regulation of IL-12-family cytokines in dendritic cells and the generation of T H-responses. Eur Cytokine Netw. (2010) 21:319–28. 10.1684/ecn.2010.0219
    1. Merritt C, Enslen H, Diehl N, Conze D, Davis RJ, Rincón M. Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8+ but not CD4+ T cells. Mol Cel Biol. (2000) 20:936–46. 10.1128/MCB.20.3.936-946.2000
    1. Zhang S, Kaplan MH. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J Immunol. (2000) 165:1374–80. 10.4049/jimmunol.165.3.1374
    1. Lanna A, Coutavas E, Levati L, Seidel J, Rustin MH, Henson SM, et al. . IFN-α inhibits telomerase in human CD8+ T cells by both hTERT downregulation and induction of p38 MAPK signaling. J Immunol. (2013) 191:3744–52. 10.4049/jimmunol.1301409
    1. Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, et al. . Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. (2009) 11:1305–14. 10.1038/ncb1975
    1. Puleston DJ, Zhang H, Powell TJ, Lipina E, Sims S, Panse I, et al. . Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife. (2014) 3:e3706. 10.7554/eLife.03706
    1. Pucciarelli S, Moreschini B, Micozzi D, De Fronzo GS, Carpi FM, Polzonetti V, et al. . Spermidine and spermine are enriched in whole blood of nona/centenarians. Rejuv Res. (2012) 15:590–5. 10.1089/rej.2012.1349
    1. Henson SM, Macaulay R, Franzese O, Akbar AN. Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade. Immunology. (2012) 135:355–63. 10.1111/j.1365-2567.2011.03550.x
    1. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, et al. . Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. (2007) 27:670–84. 10.1016/j.immuni.2007.09.006
    1. Di Mitri D, Azevedo RI, Henson SM, Libri V, Riddell NE, Macaulay R, et al. . Reversible senescence in human CD4+CD45RA+CD27− memory T cells. J Immunol. (2011) 187:2093–100. 10.4049/jimmunol.1100978
    1. Lanna A, Gomes DC, Muller-Durovic B, McDonnell T, Escors D, Gilroy DW, et al. . A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging. Nat Immunol. (2017) 18:354–63. 10.1038/ni.3665
    1. Parmigiani A, Nourbakhsh A, Ding B, Wang W, Kim YC, Akopiants K, et al. . Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep. (2014) 9:1281–91. 10.1016/j.celrep.2014.10.019
    1. Peng M, Yin N, Li MO. Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell. (2014) 159:122–33. 10.1016/j.cell.2014.08.038
    1. Chantranupong L, Wolfson RL, Orozco JM, Saxton RA, Scaria SM, Bar-Peled L, et al. . The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep. (2014) 9:1–8. 10.1016/j.celrep.2014.09.014
    1. Wang M, Xu Y, Liu J, Ye J, Yuan W, Jiang H, et al. . Recent insights into the biological functions of sestrins in health and disease. Cell Physiol Biochem. (2017) 43:1731–41. 10.1159/000484060
    1. Pearce EL. Fuelling immunity: insights into metabolism and lymphocyte function. Science. (2013) 342:1242454 10.1126/science.1242454
    1. Chisolm DA, Weinmann AS. TCR-signaling events in cellular metabolism and specialization. Front Immunol. (2015) 6:292. 10.3389/fimmu.2015.00292
    1. Arnold CR, Pritz T, Brunner S, Knabb C, Salvenmoser W, Holzwarth B, et al. T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells. Exp Gerontol. (2014) 54:75–83. 10.1016/j.exger.2014.01.018
    1. Walters HE, Cox LS. mTORC inhibitors as broad-spectrum therapeutics for age-related diseases. Int J Mol Sci. (2018) 19:E2325. 10.3390/ijms19082325
    1. Kennedy BK, Pennypacker JK. Drugs that modulate aging: the promising yet difficult path ahead. Transl Res. (2014) 163:456–65. 10.1016/j.trsl.2013.11.007
    1. Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, et al. . TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. (2018) 10:eaaq1564. 10.1126/scitranslmed.aaq1564
    1. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, et al. . mTOR inhibition improves immune function in the elderly. Sci Transl Med. (2014) 6:268ra179. 10.1126/scitranslmed.3009892
    1. Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, et al. . Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells. Blood. (2011) 117:4273–83. 10.1182/blood-2010-09-310888
    1. Weichhart T, Säemann MD. The multiple facets of mTOR in immunity. Trends Immunol. (2009) 30:218–26. 10.1016/j.it.2009.02.002.
    1. Akbar AN. The convergence of senescence and nutrient sensing during lymphocyte ageing. Clin Exp Immunol. (2017) 187:4–5. 10.1111/cei.12876
    1. Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunol Lett. (2014) 162:346–53. 10.1016/j.imlet.2014.06.006
    1. Derhovanessian E, Pawelec G. Vaccination in the elderly. Microb Biotechnol. (2012) 5:226–32. 10.1111/j.1751-7915.2011.00283.x
    1. Wells JW, Cowled CJ, Farzaneh F, Noble A. Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J Immunol. (2008) 181:3422–31. 10.4049/jimmunol.181.5.3422
    1. Haynes L, Eaton SM, Burns EM, Rincon M, Swain SL. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. J Immunol. (2004) 172:5194–9. 10.4049/jimmunol.172.9.5194
    1. Jones SC, Brahmakshatriya V, Huston G, Dibble J, Swain SL. TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism. J Immunol. (2010) 185:6783–94. 10.4049/jimmunol.0901296
    1. Duthie MS, Windish HP, Fox CB, Reed SG. Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev. (2011) 239:178–96. 10.1111/j.1600-065X.2010.00978.x.
    1. Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun. (2009) 77:1774–81. 10.1128/IAI.00086-09
    1. De Franco AL, Rookhuizen DC, Hou B. Contribution of Toll-like receptor signaling to germinal center antibody responses. Immunol Rev. (2012) 247:64–72. 10.1111/j.1600-065X.2012.01115.x
    1. Shaw AC, Panda A, Joshi SR, Qian F, Allore HG, Montgomery RR. Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev. (2011) 10:346–53. 10.1016/j.arr.2010.10.007
    1. Tye GJ, Ioannou K, Amofah E, Quartey-Papafio R, Westrop SJ, Krishnamurthy P, et al. . The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice. Immun Ageing. (2015) 12:6. 10.1186/s12979-015-0033-0
    1. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol. (2010) 184 5:2518–27. 10.4049/jimmunol.0901022
    1. Plotkin S. The history of vaccination against cytomegalovirus. Med Microbiol Immunol. (2015) 204:247–54. 10.1007/s00430-015-0388-z
    1. Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. . Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. (2017) 377:2433–44. 10.1056/NEJMoa1706640
    1. Stahl EC, Brown BN. Cell therapy strategies to combat immunosenescence. Organogenesis. (2015) 11:159–72. 10.1080/15476278.2015.1120046

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj